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Parent-Child Interaction Therapy (PCIT), an intensive parent-coaching program, 
has shown powerful behavioral effects on child welfare-involved families. PCIT is 
known to improve both parenting and child behavior as well as reduce child abuse 
recidivism among parents who have already abused their child. However, potential 
benefits of PCIT on improving parents’ physical health have not been explored. Given 
the well-documented link between psychosocial stress and physical health, 
psychosocially disadvantaged families such as those involved with child welfare are at 
heightened risk for poor health outcomes. One key pathway whereby psychosocial stress 
leads to disease is through chronic peripheral inflammation, the immune system’s 
response to repeated, stress-related activation. Several behavioral interventions have 
shown promise in reducing chronic inflammation in adults. However, no study to date 
has examined the effects of a parenting intervention on parental chronic inflammation. 
In the current study, I aimed to examine whether PCIT may lower a biomarker of 
chronic inflammation, C-reactive protein (CRP), among a sample of child welfare-
involved parents. I further aimed to explore parent risk factors that may moderate 
 
 v 
treatment effects. Results provided no evidence that PCIT lowered parent CRP, and 
tested moderators were also not significant. I review these findings in the context of 
existing literature on behavioral interventions that may impact stress reactivity and 
chronic inflammation. Future directions are discussed, including recommendations for 
future studies to measure inflammation across a full panel of inflammatory markers, to 
use longitudinal designs to assess inflammation changes as they emerge over time, and to 
employ study designs that will allow for potential psychological and physiological 
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Parent-Child Interaction Therapy (PCIT), an intensive parent coaching program, 
has demonstrated powerful effects in vulnerable families, including strengthening 
positive parenting skills, reducing harsh, aversive parenting, lowering parents’ stress, and 
improving child adjustment (Batzer, Berg, Godinet, & Stotzer, 2018; Chaffin et al., 2004; 
Chaffin, Funderburk, Bard, Valle, & Gurwitch, 2011; Cooley, Vedorale-Griffin, Petren, 
& Mullis, 2014; Thomas, Abell, Webb, Avdagic, & Zimmer-Gembeck, 2017; Timmer, 
Urqzuia, Zebell, & McGrath, 2005). However, to date, the potential physical health 
impacts of this intervention have not been examined. Given strong evidence for the link 
between psychosocial stress and physical health (e.g., Umberson, Crosnoe, & Reczek, 
2010; Holt- Lunstad, Smith, & Layton, 2010), there is a growing recognition that 
psychosocially disadvantaged families, such as those involved with child welfare, are at 
heightened risk for stress-related diseases. Thus, researchers have begun to examine 
whether psychosocial interventions known to reduce stress and improve behavioral 
functioning may also improve physiological processes implicated in the development of 
stress-related illness. The presence of low-grade bodily inflammation due to chronic, 
stress-induced immune system activation has been identified as one key physiological 
mechanism linking psychosocial stress to poor health outcomes (Bierhaus et al., 2013; 
Nusslock & Miller, 2016; Slavich & Irwin, 2014). Moreover, evidence suggests that 
some behavioral interventions, such as cognitive behavior therapy (CBT) or mindfulness-
based treatments, may be able to lower chronic inflammation in adults (Bower & Irwin, 
2016; Lopresti, 2017). Thus, in the current study, I propose to investigate potential 
 
 2 
impacts of PCIT on a biomarker of chronic inflammation in child welfare (CW)-involved 
parents. 
PCIT Outcomes among Vulnerable Families  
Parent Child Interaction Therapy (PCIT) was initially developed as a treatment 
for disruptive behavior problems among young children (ages 2-7), including issues such 
as temper tantrums, destroying objects, and defiance toward adults (e.g., Eyberg, 1995). 
Since its development, PCIT has been successfully applied to treat a range of child 
presenting problems, including internalizing problems (e.g., Carpenter et al., 2014) and 
attention-deficit/hyperactivity disorder (ADHD; Matos, Baumeister, & Bernal, 2009), and 
has been used to treat dyads in which caregiving impairments are present, with or without 
child behavioral problems (Herschel & McNeil, 2005). In PCIT, caregivers are taught a 
small set of focused parenting skills across two phases. In the first phase, Child-Directed 
Interaction (CDI), parents are taught to provide children with praise and positive attention 
for appropriate behavior and ignore minor misbehavior while following the child’s lead 
in play (Eyberg, Boggs, & Algina, 1995). In the second phase of PCIT, Parent-Directed 
Interaction (PDI), parents learn a concrete sequence of skills to gain child compliance and 
manage challenging behavior (Eyberg et al., 1995). Of note, a majority of PCIT sessions 
are delivered using an intensive, live-coaching format in which therapists give parents 
instantaneous feedback during play interactions with their child, via a one-way mirror 
and specialized audio equipment (Borrego & Urquiza, 1998).  
In addition to improving child behavioral outcomes (e.g., Thomas et al., 2017), 
PCIT has shown powerful effects on parenting behavior and parent functioning. For 
example, in one recent study of 139 Australian parents, self-reported improvements in 
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parents’ own emotion regulation were observed following PCIT (Zimmer-Gembeck, 
Kerin, Webb, Gardner, Mastro Campbell, Swan, & Timmer, 2019). PCIT’s effectiveness 
in reducing parenting stress has been also been well-documented. In their meta-analysis, 
Thomas et al. (2017) found effect sizes across 17 studies ranging from a mean difference 
(MD) of -6.98 to MD of -12.17 on the 36-item Parenting Stress Index (PSI; Abidin, 
1995). Of note, PCIT has shown to be effective even among the most psychosocially 
challenged parent samples. In their 2012 randomized controlled trial (RCT), Thomas and 
Zimmer-Gembeck assessed PCIT outcomes among a sample of 151 mothers who were at 
high risk for or had a history of child maltreatment. Participants were screened into the 
study using an initial semi-structured interview to ensure that all referred parents were 
currently at high risk to maltreat their child, evidenced by their endorsing a) regular use 
of corporal punishment, b) high levels of parental distress, and c) high levels of 
intolerance for their child’s behavior. Compared to waitlist controls, mothers who 
received PCIT reported reductions in their child’s externalizing and internalizing 
behavior, reductions in parenting stress, and were observed to display more warm, 
sensitive behavior during interactions with their child.  
Furthermore, substantial evidence shows that PCIT is effective in reducing future 
occurrences of maltreatment among parents who have already abused their child, a social 
problem for which intervention is notoriously difficult (e.g., Chaffin, Bonner, & Hill, 
2001). Chaffin and colleagues conducted the first RCT examining PCIT among parents 
who had already perpetrated child maltreatment (Chaffin et al., 2004, 2011), using a 
sample of parents with severe, chronic child welfare services histories (i.e., majority of 
their children removed from their care). In this set of studies, 19% of parents receiving 
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PCIT had additional reports to child welfare at 18 months post-treatment, compared to 
49% recidivism rates among those in the treatment as usual group (Chaffin et al., 2004, 
2011). In concordance with this, a meta-analysis of PCIT outcomes among maltreating 
parents revealed the intervention was associated with lower rates of re-abuse across 11 
controlled trials (Batzer, Berg, Godinet, & Stotzer, 2018). Indeed, PCIT may be the only 
parenting intervention shown to reduce future recidivism among parents who have 
already abused their child.  
Socioeconomic Risk and Psychosocial Stress in Child Welfare-Involved Families  
Socioeconomic disadvantage is a strong predictor of child welfare (CW) 
involvement (e.g., Cameron & Freymond, 2006; Courtney, Dworsky, Piliavin, & Zinn, 
2005) and CW-involved families experience high levels of psychosocial stress related to 
low socioeconomic status (SES) conditions and associated impacts on family functioning. 
For example, low-income families frequently experience stressors such as transportation 
problems, financial problems, parent work overload, or family member medical problems 
(Brown, Seyler, Knorr, Garnett, & Laurenceau, 2016), which can in turn adversely 
impact parenting (Evans, Eckenrode, & Marcynyszyn, 2009) and lead to parent 
depression and anxiety symptoms over time (Santiago, Wadsworth, & Stump, 2011). 
Indeed, low income and CW-involved parents report elevated levels of parenting stress, 
compared to their higher SES counterparts (Raphael, Zhang, Liu, & Giardino, 2010; 
Rodriguez-Jenkins & Marcenko, 2014). Parenting stress, defined as the emotional and 
physical fatigue caregivers experience when demands of parenting are perceived to 
exceed their ability or resources to cope (Deater-Deckard, 2004), is a particular form of 
relational stress known to negatively influence parenting behavior and child outcomes 
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(Crnic, Gaze, & Hoffman, 2005; Gutermuth et al., 2005; Huth-Blocks & Hughes, 2008). 
Taken together, the existing evidence demonstrates that child-welfare involved families 
are likely to be exposed to elevated levels of psychosocial stress, including parenting 
stress, which may leave them at greater risk for poor health outcomes (Matthews & Gallo 
2010; Sapolsky, 2004).  
Chronic Inflammation and Stress-Related Disease 
In recent years, social and medical science have significantly advanced 
understanding of the neurobiological processes whereby chronic psychosocial stress, 
particularly in early childhood, disrupts multiple physiological systems, leading to altered 
stress responsivity and exaggerated immune system response (Miller, Chen, & Parker, 
2011; Shonkoff et al., 2012). Within the body’s complex, multisystemic response to 
stress, chronic, low-grade inflammation has been implicated as a key driver in the 
development of stress-related disease (Bierhaus et al., 2013; Nusslock & Miller, 2016; 
Slavich & Irwin, 2014). Time-limited periods of acute inflammation in response to 
infection or injury are an essential, life-saving function of the immune system. However, 
chronic inflammation, indexed by underlying, low levels of peripheral pro-inflammatory 
cytokines (e.g., interleukin-6, interleukin-1, tumor necrosis factor alpha) and acute phase 
proteins (e.g., C-reactive protein), has harmful effects (Slavich, 2015). Chronic, low-
grade inflammation has been linked to a host of psychiatric disorders (Haroon, Raison, & 
Miller, 2012) and diseases, including leading causes of death in the U.S. such as heart 
disease (Araujo et al., 2009), stroke, diabetes (Hotamisligil, 2006; Ridker, 2007), and 
certain cancers (Berasain, Castillo, Perugorria, Latasa, Prieto, & Avila, 2009; Yao & 
Rahman, 2009).  
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One biomarker of chronic, low-grade inflammation is C-reactive protein (CRP). 
CRP is a proinflammatory acute phase protein generated in the liver, under the 
transcriptional control of the cytokine IL-6 (Pepys & Hirschfield, 2003). Circulating 
levels of CRP, collected through blood plasma samples, represent a non-invasive measure 
of systemic inflammation. Whereas expected levels of blood plasma CRP in healthy 
samples range from 0.8mg/L to 3.0 mg/L, CRP can rise to levels as high as 100-500 
mg/L in response to acute infection. The development of highly sensitive assay 
technology has allowed researchers and medical practitioners to detect slight elevations 
in CRP (e.g., 3.0 mg/L – 10 mg/L) that indicate chronic, low-grade inflammation. This 
biomarker is recommended for early risk detection and treatment planning among 
medical doctors by organizations such as the American Heart Association and Center for 
Disease Control (Pearson et al., 2003) and has increasingly been utilized by social 
science researchers to deepen understanding of how behavioral and environmental factors 
may influence immune responses to stress.  
Predictors of Elevated CRP 
A wide range of physiological, behavioral, and environmental factors can 
influence circulating levels of CRP and other pro-inflammatory markers. Low-grade 
inflammation is associated with sleep problems (Irwin, Olmstead, & Carrol, 2016), 
abdominal adiposity (Brooks, Blaha, & Blumenthal, 2010; Lapice, Maione, Patti, 
Cipriano, Rivellese, Riccardi, & Vaccaro, 2009) and obesity (Aronson, Bartha, Zinder, 
Kerner, Markiewicz, Avizohar, Brook, & Levy, 2004). Conversely, physical exercise and 
nutrient-dense diet are both known to reduce inflammation (Fedewa, Hathaway, & Ward-
Ritacco, 2017; Kuczmarski, Mason, Allegro, Zonderman, & Evans, 2013; de Maat & 
 
 7 
Kluft, 2001). CRP levels increase with age (de Maat & Kluft, 2001) and are often higher 
among women (Khera et al., 2009) and non-White ethnic groups (Nazmi & Victora, 
2007). Elevated CRP levels are associated with smoking (de Maat & Kluft, 2001; van der 
Vaart et al., 2005) and exposure to air pollutants (Pilz et al., 2018). There is also a well-
documented, inverse association between chronic inflammation and SES (Gruenewald, 
Cohen, Matthews, Tracy, & Seeman, 2009; Panagiotakos et al., 2004). Some studies 
suggest the association between socioeconomic disadvantage and inflammation may be 
best explained by high levels of psychosocial stress experienced by those living in 
poverty (Hong, Nelesen, Krohn, Mills, & Dimsdale, 2006). Alternatively, other findings 
indicate the link between low SES and inflammation may be driven by environmental 
conditions of poverty that impact health more broadly (e.g., through illness or body mass 
index; Alley, Seeman, Kim, Karlamanga, Hu, & Crimmins, 2006), However, there is 
growing public interest in the link between chronic, low-grade inflammation and 
psychosocial stress, given that this factor may be more readily intervened on by health 
care providers.  
Psychosocial Stress and CRP 
Chronic psychosocial stress is associated with low-grade inflammation in 
adulthood (Gouin, Glaser, Malarkey, Beversdorf, & Kiecolt-Glaser, 2012). For example, 
elevated levels of circulating CRP and inflammatory cytokines have been observed in 
populations known to face significant, ongoing stressors, such as family caregivers of 
critically ill patients (Gouin et al., 2012; Sherwood et al., 2016) or immigrants to the 
United States (Ablow Measelle, McClure, Snodgrass, Martinez, Jimenez, & Isiordia, 
2019). In their Social Transduction Theory of Depression, Slavich and Irwin (2014) 
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outline how experiences of psychosocial stress work to upregulate immune activity, 
leading to chronic inflammation. Inflammatory activity is regulated by neurological stress 
response processes, such as activity in the sympathetic nervous system (SNS) and 
hypothalamic pituitary adrenal (HPA) axis and responds to activity in these systems in 
order to prepare against physical injury. For example, in the SNS, the release of the 
neurotransmitter norepinephrine into peripheral tissues results in increased transcription 
of pro-inflammatory immune response genes (i.e., IL1, TNF, and IL6) and in the release 
of pro-inflammatory cytokines. While this anticipatory immune response is evolutionarily 
adaptive and prepared our ancestors for wound healing following a physical attack 
(Antoni et al., 2012) chronic immune activation in response to present-day social 
stressors results in long-term inflammation and health risk (Irwin & Cole, 2011; Slavich 
& Irwin, 2014).  
How significant or prolonged must psychosocial stress be in order to lead to 
peripheral inflammation? There is evidence that stress related to the quality of daily 
interactions with partners, family members, and friends can influence inflammatory 
markers (Chiang, Eisenberger, Seeman, & Taylor, 2012; Fuligni, Telzer, Bower, Cole, 
Kiang, & Irwin, 2009; Marin, Chen, Munch, & Miller, 2009; Kiecolt-Glaser, Gouin, & 
Hantsoo, 2010). In one study, a sample of 69 adolescents was asked to complete a daily 
diary in which they reported on their experiences of negative interactions at home and at 
school, including conflict with family and friends, peer harassment, and punishment by 
parents or teachers. Blood samples collected 8 months later showed that greater daily 
negative interactions were associated with higher CRP, even after controlling for body 
mass index, socioeconomic status, substance abuse, life events, rejection sensitivity, 
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psychological distress, and frequency of daily interpersonal stressors 2 years prior 
(Fuligni, Telzer, Bower, Cole, Kiang, & Irwin, 2009). In keeping with Slavich & Irwin’s 
theory (2014), this finding suggests that the experience of social threat and even more 
subtle elevations in interpersonal stress are, indeed, salient to the immune response, with 
critical implications for long-term health. Given this, interventions that reduce 
interpersonal stress and improve the quality of key relationships may also have the 
potential to confer important health benefits.  
Behavioral Interventions Can Impact Physiological Stress Response  
A growing body of evidence suggests that psychosocial interventions can effect 
change in neurobiological stress systems, as well as behavior. For example, Dozier and 
colleagues have found that their attachment-based intervention, Attachment and 
Biobehavioral Catch-Up (ABC), which targets caregivers’ support of young children’s 
regulatory capabilities, also normalizes cortisol production among maltreated/child 
welfare-involved children (Bernard, Dozier, Bick, & Gordon, 2015; Bernard, Hostinar, & 
Dozier, 2015; Dozier, Peloso, Lewis, Laurenceau, & Levine, 2008). In a randomized 
clinical trial of 101 infants and toddlers judged by Child Protective Services to be at-risk 
for neglect, those children who received ABC showed a more typical post-treatment 
diurnal cortisol response, including higher waking cortisol levels and steeper diurnal rise, 
compared to children who received a control intervention (Bernard, Dozier, Bick, & 
Gordon, 2015). Further, ABC’s effects on normalization diurnal cortisol regulation 
persisted for three years following treatment (Bernard, Hostinar, & Dozier, 2015). 
Similarly, Fisher & Stoolmiller (2008) reported findings from a randomized controlled 
trial of Multidimensional Treatment Foster Care for Preschoolers (MTFC-P) where the 
 
 10 
intervention resulted in reduced caregiver stress and normalized diurnal cortisol response 
among preschoolers, relative to a comparison group.  
Although this literature is more nascent, there is some evidence that psychosocial 
interventions may also be able to reduce chronic inflammation. Current evidence for this 
is perhaps strongest in the depression treatment literature. Cognitive behavior therapy 
(CBT), long known to be effective in reducing depression symptoms, has also shown 
potential to lower inflammatory markers in adults (for a review see Lopresti, 2017). 
Randomized controlled trials comparing CBT to control groups (e.g., Zabihiyeganeh et 
al., 2019), or to alternate depression treatments (e.g., Moreira et al., 2015) have shown 
significant post-treatment reductions in serum levels of pro-inflammatory cytokines, such 
as IL-6 and TNF-α and acute phase proteins (i.e., CRP), although some studies in this 
area have found no effect on inflammatory markers (Claesson et al., 2006 ) or even post-
CBT increases in participant inflammation (Berk et al., 2015; Keri, Szabo, & Kelemen, 
2014). Mind-body therapies (MBTs), such as Tai Chi, Qigong, yoga, and meditation, 
have also shown promise in lowering inflammation (Bower & Irwin, 2016). In their 2016 
qualitative review, Bower and Irwin discuss positive treatment effects in adults seeking 
treatment for sleep disturbance or stress related to medical conditions, demonstrated by 
post-treatment reductions in circulating levels of CRP, cellular markers of inflammation, 
and inflammation-related gene expression, although null results have also been 
documented (e.g., Bower et al., 2014; Irwin & Olmstead, 2012). Some trials investigating 
inflammation among older adults with sleep disturbance have compared mind-body 
therapies to a form of CBT adapted to treat insomnia, with similar reductions on 
inflammatory markers observed across these treatments (Irwin et al., 2014, 2015). Given 
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that CBT and MBTs can achieve comparable effects on inflammation, despite differences 
in treatment modality, potential mechanisms of these interventions may provide insight 
about how behavioral therapies can work to lower inflammation.  
Mechanisms for the effect of CBT on inflammation have not yet been empirically 
examined. However, researchers have suggested (Lopresti, 2017) that CBT may work to 
reduce inflammation through increasing patients’ use of a variety of positive coping 
strategies that reduce stress as well through lifestyle improvements linked to lower 
inflammation, including the use of relaxation strategies (Kang et al., 2011), engagement 
in daily pleasurable activities (Sin, Graham-Engeland, & Almeida, 2015), or improved 
sleep (Irwin, Olmstead, & Carroll, 2016). MBTs have been better studied in this regard 
and are thought to lower inflammation by reducing stress reactivity. Active ingredients of 
MBTs include focused attention, controlled breathing, and physical movement (Bower & 
Irwin, 2016). Thus, CBT and MBTs likely influence immune activity through stress 
reduction, although they may also lower inflammation through positive lifestyle changes 
such as increased physical activity or improved sleep. It therefore follows that an 
intervention targeting relational quality and reducing relational stress, such as PCIT, may 
also confer benefits on lowering inflammation. Moreover, whereas CBT and MBTs have 
been assessed primarily in samples of adults with depression or medical conditions 
(Bower & Irwin, 2016; Lopresti, 2017) it is unknown whether behavioral treatments can 
reduce inflammation among psychosocially disadvantaged parents, making this an 
important gap in existing literature.  
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I am aware of only one study to date that has examined effects of a parent-
coaching program for vulnerable families on inflammation, albeit among youth, rather 
than parents. In 2014, Miller and colleagues studied the biobehavioral effects of a family 
intervention delivered to low-SES, African American mothers and their 11-year-old child 
in the rural South (Miller, Brody, Yu, & Chen, 2014). The sample included 272 families 
who were randomly assigned to receive the psychosocial intervention Strong African 
American Families (SAAF) or to the control condition. SAAF targets increasing 
parenting skills, strengthening family relationships, and building children’s competencies 
(Brody et al., 2004) and was delivered across seven weekly sessions. At an 8-year follow-
up assessment, when participating youth were 19-years-old, chronic inflammation was 
measured via circulating levels of six major pro-inflammatory cytokines (i.e., IL 1β, -6, -
8, and -10, tumor necrosis factor α, IFN-γ) in peripheral blood samples. Those youth 
whose families received the SAAF intervention showed significantly less chronic, low-
grade inflammation than controls, demonstrated by lower levels of cytokine production. 
Further, the effect of the intervention on lowering youths’ chronic inflammation was 
shown to be partially mediated by mothers’ improved parenting skills (Miller, Brody, Yu, 
& Chen, 2014). These results demonstrate that even a relatively brief family intervention 
may yield lasting benefits in reduced peripheral inflammation with profound health 
implications, and that improving parenting skills is one mechanism for this powerful 
effect. However, no study to date has examined whether such behavioral interventions 




Current Study  
Given that behavioral interventions can lower inflammation in adults and 
parenting interventions can lower chronic inflammation in adolescent offspring, I 
reasoned that a parenting intervention may also exert a positive impact on lowering 
inflammation in participating parents. The current project addressed this gap in the 
literature by testing the following aims: 
 Aim 1): Investigate the effects of PCIT on a biomarker of chronic inflammation 
(CRP) among CW-involved parents. H1. Parents randomly assigned to receive PCIT will 
display lower levels of CRP at post-treatment, relative to family services-as-usual (SAU) 
controls. Aim 2): Test whether PCIT lowers parents’ inflammatory markers through 
reductions in parenting stress. H2. PCIT-driven reductions in parenting stress will 
mediate the effect of PCIT on post-treatment reductions in parental CRP. Aim 3): 
Explore parent characteristics and family risk factors that may moderate the effect of 
PCIT on parent CRP, including parent age, parent sex, and exposure to early adversity. 
H3. Although this final aim is exploratory, evidence suggests that behavioral 
interventions may confer greater inflammatory reductions among those with higher 
inflammation (Morgan et al., 2014), at study entry. Therefore, I explored whether the 
impact of PCIT on CRP will be amplified among mothers versus fathers (Khera, Vega, 
Das, Ayers, McGuire, Grundy, & Lemos, 2009), older parents (Lowe, 2005), and among 







Data were drawn from a larger NIDA-funded, randomized clinical trial of PCIT 
versus family services as usual (SAU) in n = 204 child welfare-involved parents and their 
3 to 8-year old children (R01DA036533). Participants in the current study are n = 199 
parents from whom CRP was collected at baseline and post-treatment. Participants were 
recruited via direct correspondence with their child welfare or self-sufficiency case 
worker within a local Department of Human Services (DHS) office. In order to be 
eligible for the study, participating parents were primary caregivers to their participating 
child, living together at least 50% of the time and had current DHS involvement via child 
welfare or self-sufficiency services. A majority of parents (97%) were the child’s 
biological parent; participating caregivers were also the child’s grandparent (1%), 
adoptive parent (.5%) or other relative (1%). Parents were 12% male and 88% female and 
ranged in age from 18 to 50 years (M = 32.30, SD 6.43). Parents were 70.8% European 
American/White, 2.6% Hispanic/Latino/a, 2.1% African American/Black, 1.0% Pacific 
Islander, 1.5% Native American, 20.4% multi-ethnic, and 1.5% unknown. Regarding 
socioeconomic indicators, 49% of parents reported having completed at least high 
school/GED certificate, 44% reported receiving temporary assistance for needy families 
(TANF) aid, and 54.5% of parents reported being unemployed. A majority (81%) of 
parents reported being single. Participating children were 54.6% male and 45.4% female 





As part of the larger parent study, biobehavioral assessments of parents and 
children were conducted at the University of Oregon in three waves: pre-
treatment/baseline (Wave 1), mid-treatment (Wave 2) for PCIT condition families only, 
and post-treatment (Wave 3) for PCIT intervention and SAU control condition families. 
The post-treatment assessment occurred approximately 6 months following the baseline 
assessment for SAU families (M = 7.21 months, SD = 1.86, range = 5 to 18 months) and 
immediately following treatment completion for PCIT families (time from baseline 
assessment: M = 7.79 months, SD = 2.65, range = 3 to 16 months). At each assessment 
wave, families completed two laboratory visits lasting approximately 2-3 hours, during 
which a range of biobehavioral measures were collected, including behavioral 
observations of parent–child interactions, autonomic physiology (respiratory sinus 
arrhythmia and pre-ejection period), high density EEG, behavioral and survey measures 
of self-regulation, socio-demographics, and biomarkers of health such as blood pressure, 
height, weight, spirometry, and blood spots.  
Measures for the current study were collected at Waves 1 (baseline) and 3 (post-
treatment). During visit 1, parents were read and given a copy of the informed consent 
document and provided consent for themselves and their children to participate. The 
family’s DHS caseworker provided study consent for children when they were not in 
parents’ legal custody, though living together with parent. Parents’ height (in cm) and 
weight (in kg) was collected using a digital scale and stadiometer to calculate body mass 
index (BMI). Parents’ waist circumference was measured in cm while in a relaxed, 
standing posture by a research assistant using a plastic measuring tape over bare skin, 
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using the top of the iliac crest as a bony landmark. Next, parents completed a brief 
demographic interview in which they reported on their age, racial/ethnic identity, 
household income, and subjective ratings of SES relative to their own community and to 
the United States. They were also asked whether they have a list of common health 
problems (e.g., high blood pressure, diabetes, asthma) and if they had taken medications 
during the last 24 hours.  
Families returned for a second laboratory visit approximately one week later. At 
this assessment visit, parents completed standardized questionnaires reporting on their 
parenting stress, current mental health symptoms, and exposure to childhood adversity. 
To accommodate variations in parent literacy, a trained research assistant read 
questionnaire items aloud and provided a card displaying item response options. The 
research assistant recorded participant responses on a laptop computer. Next, blood spots 
were obtained from parents. Trained research assistants wiped the fingertip with an 
alcohol pad and made a single finger prick using a sterile, disposable micro-lancet which 
is triggered, then discarded in a biohazard container. For each consenting parent, five full 
drops of whole blood were collected on sterile Whatman 903 TM filter paper, after which a 
bandage was applied. The filter paper was dried at room temperature for 24 hours, then 
placed in individual plastic bags with desiccant and temporarily stored in a small, in-lab 
freezer. Samples were periodically transferred for long-term storage in a padlocked, -
800C freezer located in a secure area of the University of Oregon Human Biology 
Research Laboratory.  
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At the conclusion of the second research visit in Wave 1, parents were given a 
sealed envelope with a letter explaining whether they had been randomly assigned to the 
SAU control condition or to receive PCIT. Families could take a brief break midway 
through each assessment visit and were provided with a snack. At the end of each 
laboratory visit, parents were paid ($100 for visit 1, $75 for visit 2), compensated for 
transportation, and their children received a prize. The study was approved by the 
University of Oregon Institutional Review Board and the State of Oregon Department of 
Human Services IRB.  
Intervention. PCIT was delivered to randomized families in weekly sessions at 
the University of Oregon clinic. Prior to the standard PCIT package, we employed a 
motivational enhancement treatment (MET) component used with child welfare-involved 
families by Chaffin and colleagues (Chaffin et al., 2009), adapted for use in individual 
sessions. Specifically, in consultation with PCIT master trainer Beverly Funderburk, we 
developed a two-session, individual MET component derived from the original, six-
session group format MET employed in Chaffin et al (2004)’s clinical trial. The 
intervention was delivered by 8 therapists, including 6 doctoral graduate students who 
had obtained a masters’ degree, a licensed social worker, and licensed psychologist. All 
therapists were trained by master PCIT trainers and received weekly remote consultation 
and live in-session supervision with a master PCIT trainer at the University of Oklahoma. 
Therapists completed a fidelity checklist at the conclusion of each session and 
independent raters monitored fidelity to the treatment model by coding session 
videotapes. Therapists were required to maintain an 80% or greater level of fidelity.  
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Families were over-allocated to the intervention group at a rate of 1.5:1 to ensure 
a sufficient number of families accessed the intervention. Thus, 122 parents were 
randomly assigned to receive PCIT, whereas 84 were assigned to the control group (i.e., 
family services as usual in the community). Treatment group allocation was made using a 
computerized random number table and allocation was concealed to participants and 
experimenters using a sealed envelope. Of the parents assigned to the PCIT condition, 88 
(72%) attended at least one treatment session; 65 (53%) completed the first phase of 
treatment, CDI, and 49 parents (40.9%) received a full course of CDI and PDI sessions, 
defined as completing at least three PDI sessions. Of those who engaged in treatment 
(i.e., attended at least one session), the average number of sessions received was 12 
(range = 1 to 31).  
Control condition (Family Services-as-Usual). Families randomized to the 
control condition were free to access the range of social services available in the 
community. This is an ethical, ecologically valid alternative to a strict control condition 
for vulnerable families. At the post-treatment assessment, parents were asked to report on 
their families’ participation in social and behavioral support services (e.g., counseling, in-
home therapy services, skills coaching, case management, etc.) during the prior 6 months. 
Measures  
C-Reactive Protein 
Parents’ dried blood spots (DBS) were assayed to ascertain levels of CRP using 
high-sensitivity enzyme-linked immunosorbent assays (ELISA). Blood spot measurement 
of CRP is used in epidemiological studies (e.g., McDade, Williams, & Snodgrass, 2007; 
 
 19 
McDade et al., 2006; Williams & McDade, 2009) and is shown to provide accurate 
assessment of CRP, commensurate with levels obtained through venous blood serum 
collection. Collection time of DBS was variable; however, CRP does not show diurnal 
variation (Meier- Ewert et al., 2001). CRP remains stable in DBS for at least 5 days at 
room temperature or 14 days at 4 degrees C and are stable for years when stored at -80 
degrees C. Following ELISA, serum equivalents were calculated using the following 
algorithm: serum (high-sensitivity CRP) = 1.38 * (blood spot CRP value) −.97 (McDade 
et al. 2006). Higher values indicate greater levels of systemic inflammation. Expected 
levels of blood plasma CRP in healthy samples range from 0.8mg/L to 3.0 mg/L, whereas 
levels greater than 10.0 mg/L indicate frank infection. Figures 1 shows distributions for 
raw parent CRP DBS concentrations at pre- and post-treatment. After excluding 
extremely high values, parents showed mean CRP levels of 2.39 mg/L at baseline (SD = 
3.17) and 2.02 mg/L at post-treatment (SD = 2.39). Parent CRP levels were in a range 
typically associated with chronic, low-grade inflammation (i.e., between 3.0 mg/L and 







Figure 1. Distribution of raw CRP concentrations for parents at baseline (A) 











Figure 2. Distribution of baseline parent CRP among parents in the 












Figure 3. Distribution of post-treatment parent CRP among parents in the PCIT 







Parents completed a semi-structured interview in which they reported on their 
age, race/ethnicity, socioeconomic indicators, and tobacco use. Number of cigarettes 
smoked per day was measured using a single self-report item: “In general, how many 
cigarettes do you smoke per day?” A variety of socioeconomic indicators were collected 
including: household income, parent employment status and hours worked, and parent 
educational attainment. The MacArthur Scale of Subjective Social Status (Adler, Epel, 
Castellazzo, & Ickovics, 2000) was used to collect parents’ subjective SES ratings. 
Parents were presented with an image of a ten-rung ladder representing “where people 
stand,” with higher rungs representing higher standing (i.e., “more education, more 
money, better jobs”), and asked to indicate a rung reflecting how “well-off” they 
considered themselves in relation to others, first within their community and then in 
relation to others across the entire United States. Possible scores on this measure range 
from 1 to 10, with higher scores reflecting higher perceived SES. 
Parents reported a mean subjective SES ranking of 5.01 (SD = 1.84) relative to 
their community and mean subjective SES ranking of 3.97 (SD = 1.98) relative to the 
entire U.S. Parents reported smoking between 0 and 30 cigarettes per day (M=4.53, 
SD=6.31), with 52% indicating daily cigarette use. Body mass index (BMI) was 
calculated for parents at each wave of data collection using kg/m2. Baseline BMI score 





Adverse Childhood Experiences 
Parent exposure to adverse childhood experiences (ACEs) was assessed using the 
ACEs Questionnaire (Dube et al., 2013; Felitti et al., 1998). The ACEs Questionnaire has 
been adapted to retrospectively assess the various forms of adverse experiences identified 
as long-term health risks in the original Kaiser Permanente epidemiological study (Felitti 
et al., 1998). Parents were asked whether they experienced a standard list of 10 adverse 
experiences before the age of 18 and could respond yes or no. Items assessed experiences 
related to childhood abuse (i.e., psychosocial, physical, or sexual), neglect (i.e., emotional 
or physical), and exposure to household dysfunction (i.e., substance abuse, parental 
separation/divorce, mental illness, battered mother, criminal behavior). For example, one 
item reads: “While you were growing up, during your first 18 years of life, did you often 
feel that you didn’t have enough to eat, had to wear dirty clothes, and had no one to 
protect you?” Scores are summed across items, with higher scores indicating greater 
exposure to adversity. Parents reported an average of M = 5.18 adverse childhood 
experiences (SD=2.71). The distribution of parent ACE scores is shown in Figure 4; 
73.2% of parents reported experiencing 4 or more adverse childhood experiences, a cut-








Parents reported on parenting stress levels using the Parenting Stress Index, 
Fourth Edition Short Form (PSI-4SF; Abidin, 1995). The current study included two of 
the three original subscales, the Parent-Child Dysfunctional Interaction and Difficult 
B 
Figure 4. Distribution of parent adverse childhood experience (ACE) scores (A) and 




Child subscale, comprising 24 items. Parents responded to a series of statements 
describing their child using a 5-point Likert scale (1 – strongly disagree to 5- strongly 
agree). Items for the Parent-Child Dysfunctional Interaction subscale include statements 
such as “Sometimes I feel my child does not like me.” Items for the Difficult Child 
subscale include items such as, “My child is very moody and easily upset.” Responses are 
summed across items for each subscale, with higher scores indicating greater levels of 
parenting stress. The PSI has demonstrated strong psychometric properties in community 
samples (Haskett, Ahern, Ward, & Allaire, 2006; Whiteside-Mansell, Ayoub, McKelvey, 
Faldowksi, Hart, & Shears, 2007) as well as in low- income, samples of parents with 
preschool children (i.e., Head Start; Reitman, Currier, & Stickle, 2002). Internal 
consistency in the current sample was high for both the Parent-Child Dysfunctional 
Interactions subscale (Cronbach’s α = .83) and the Difficult Child subscale (Cronbach’s α 
= .81). At baseline, 37% of parents’ Dysfunctional Parent-Child Interactions scores fell 
within the elevated range (i.e., above 80th percentile; M= 22.85, SD = 6.64) and 46.4% of 
Difficult Child scores fell within the elevated range (M = 30.02, SD = 7.95).  
Depression Symptoms.  
Parent depression symptoms were measured using the Depression subscale of the 
Brief Symptom Inventory (BSI; Derogatis & Spencer, 1982), an abbreviated 
psychological symptom checklist. The BSI has demonstrated strong psychometric 
properties (Boulet & Boss, 1991), including when administered to economically 
disadvantaged community samples (Prelow, Weaver, & Swenson, 2005). The depression 
subscale comprises 6-items of the 53-item inventory. Parents were asked to report how 
much they have been “bothered by” depressive symptoms such as “Feeling no interest in 
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things” during the past week on a 5-point Likert scale ranging from 0 (not at all) to 4 
(very much). Internal consistency for the depression subscale in the current sample was 
high (Cronbach’s α = .85). For ease of interpretation, raw scores were converted to 
standardized T-scores using non-clinical population norms. Clinically elevated scores 
(i.e., T score > 63 were observed among 24% of parents at baseline (M = 55.86, SD = 


















Data Screening  
I screened the raw data for outliers and examined the distributions for key study 
variables by visually inspecting histograms and conducting skewness tests. Figures 1 and 
shows histograms for raw parent CRP levels at baseline and post-treatment within the full 
sample. Figures 2 and 3 display parent CRP at baseline and post-treatment, partitioned by 
treatment condition. Consistent with previous studies (e.g., Nelson et al., 2017; Taylor et 
al., 2006), parent CRP data were highly positively skewed and so I performed a 
logarithmic transformation for both baseline and post-treatment CRP data, after following 
procedures for assessing and imputing missing data described below. Distributions for all 
other key study variables were found to be within acceptable limits (i.e., skewness 
statistic not greater than 1.0 or less than -1.0).  
Exclusions 
In keeping with previous studies (McDade et al., 2006; Snodgrass et al., 2007; 
Taylor et al., 2006), I excluded parents with extremely high CRP values indicative of 
acute infection (i.e., >10mg/L) as well as parents who reported having taken the 
following major anti-inflammatory medications in the 24 hours prior to each wave of 
DBS collection: antihistamines, NSAIDs, corticosteroids, cold and flu medications 
(Assanasen & Naclerio, 2002; El-Sharraway, El-Hakim, & Sameeh, 2006; Mainous & 
Pearson, 2003). Reported medication usage for the sample was high: 48.5% of parents at 
baseline and 69.6% of parents at post-treatment reported any medication use prior to DBS 
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collection. Further, parents did report using other medications with potential anti-
inflammatory effects which I determined not to exclude (i.e., statins, anti-depressants, 
opioids, cannabis). Use of any medication with prior evidence of anti-inflammatory 
effects was reported by 35.8% of parents at baseline collection and 49.1 % of parents at 
post-treatment. Sensitivity analyses revealed that results across analyses were unchanged 
when I excluded parents who used any potential anti-inflammatory medication versus 
only those who used the major anti-inflammatory medications listed above.  
For baseline CRP, 9 parents were excluded due to CRP levels >10 mg/L and 41 
were excluded due to major anti-inflammatory medication usage. For post-treatment 
CRP, 3 parents were excluded due to levels > 10 mg/L and 29 parents were excluded 
based on recent, major anti-inflammatory medication usage. Given that different parents 
were excluded at each wave, this resulted in a complete analytic sample of n = 85. 
Missing Data 
Baseline missing data analysis. Prior to conducting analyses, I examined rates of 
missing data among study variables. At baseline, rates of missing data were minimal for 
key study variables: less than 2% missing for parent CRP, less than 1% missing for 
parenting stress (PSI scores), and complete data were obtained for parent depression 
symptoms (BSI scores) and parent ACEs scores. Missing data were observed in some 
baseline demographic variables: 21.48% of household income cases were missing due to 
an anomaly in data processing that led parents’ reports of no income to be designated as 
missing, and 6.71% of parents’ subjective SES ratings were missing. Although true 
missing baseline CRP data were nominal, I determined to consider excluded cases at 
baseline as missing CRP for purposes of missing data exploration and imputation, 
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because this approach allowed me to assess both waves of CRP data simultaneously, with 
optimal statistical power. Including the removed cases as discussed above, baseline CRP 
was missing for 26.12% of the sample. I explored the mechanism for missing data at 
baseline using Little’s Missing Completely at Random (MCAR) test (Little, 1988) in 
RStudio v. 3.6. The chi-square result was not statistically significant, χ2 (64) = 82.45, p = 
.06, thus failing to reject the null hypothesis that data were missing completely at 
random.  
Post-treatment missing data analysis. At post-treatment, parent CRP data were 
missing for 58 cases (36% of the post-treatment dataset, after exclusions). Missing post-
treatment CRP data were due to: parent drop-out from the study (38 cases), blood 
samples available but not yet assayed (16 cases), parent attended post-treatment 
assessment but DBS were not acquired (i.e., unsuccessful finger stick, assessors ran out 
of time; 3 cases), or because parent refused (1 case). Post-treatment observations were 
also missing for body mass index (27.10%), parent depression scores (25.90%) and 
parenting stress (30.72%) due to non-return to one (4 cases) or both post-treatment 
assessment visits (39 cases) or because assessors ran out of time to administer all 
measures (2 cases). For post-treatment data, Little’s MCAR test (Little, 1998) results also 
failed to reject the hypothesis that data were missing completely at random, χ2 (13) = 
48.04 p = .65. 
Based on these results, I next conducted multiple imputation for the above pre-
treatment and post-treatment variables with missing data using the fully conditional 
specification method in SPSS. CRP observations excluded due to extremely high 
concentration levels or to medication use were considered missing for baseline, but 
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removed for post-treatment, in order to produce a single, imputed dataset that allowed for 
pre- and post-treatment CRP to be analyzed together. To address potential bias that may 
have been introduced through multiple imputation, I compare main analyses below using 
both the imputed data and complete case data.  
I also conducted attrition analyses to explore whether patterns of missing data at 
post-treatment were related to baseline variables by creating dummy codes (i.e., 
1=missing, 0=not missing) for key study variables and performing a series of chi-square 
tests (for categorical variables) and independent samples t tests (for continuous variables) 
in SPSS v. 26 to assess whether rates of attrition were related to any other study 
variables. Patterns of missing data across key study variables were not found to be related 
to parent and family characteristics (i.e., parent age, parent sex, parent race/ethnicity, 
parent educational attainment, child age, household income) nor to baseline levels of 
study variables.  
Assessing Equivalence of Treatment and Control Groups Due to Randomization 
 To assess whether the PCIT and SAU control groups created through 
randomization were equivalent at study entry, I performed a series of independent 
samples t-tests on baseline key study variables and select demographic characteristics, 
using complete cases. Results indicated baseline, raw CRP levels were not statistically 
significantly different between parents randomized to the treatment (M = 1.76, SD=1.94) 
and control groups [M = 1.69, SD=1.91; t (163) = -.27, p = .79]. Baseline parenting stress 
scores were also not significantly different between groups, for PSI Dysfunctional Parent-
Child Interactions scores [PCIT M = 22.78, SD = 6.55; Control M = 22.82, SD = 6.30; t 
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(163) = .03, p = .98] or PSI Difficult Child scores [PCIT M = 30.03, SD = 8.17; Control 
Group M = 29.02, SD = 7.60; t (163) = -.77 p = .45]. Further, there were no statistically 
significant differences between treatment groups in regards to parent age [PCIT Mage = 
32.10 years, SD = 5.96; Control Mage = 31.56 years, SD = 6.00; t (163) = .54, p = .59], 
ACE score [PCIT M = 5.18 , SD = 2.81, Control M = 5.25, SD = 2.52; t (163) = .14, p = 
.29], BSI depression score [PCIT M = 56.00 , SD = 9.42, Control M = 55.64 , SD = 9.33; t 
(163) = -.27, p = .79], or subjective SES ratings within a parent’s community [PCIT M = 
5.04, SD = 1.66; Control M = 4.95, SD = 2.02; t (151) = -.26, p = .80] or the United States 
[PCIT M = 3.95 , SD = 2.02; Control M = 3.90 , SD = 2.00; t (151) = .13, p = .90]. Using a 
cross-tabulation analysis, I also confirmed that rates of male and female parents did not 
significantly differ across the PCIT (87.5% female, 12.5% male) and control (83.6% 
female, 16.4% male) groups, χ2 (1) = .45 p = .50.  
Preliminary Results 
Descriptive statistics using complete cases (without imputation) for all study 
variables across the full sample, treatment, and control group are shown in Table 1. Zero-
order correlations among all study variables at baseline are shown in Table 2.1 using 
multiple imputation data and in Table 2.2 using complete cases. The same pattern of 
associations was observed using complete and original data. Specific statistical results 
reported below are drawn from the imputed correlation matrix. Parents’ baseline BSI 
Depression scale scores were positively related to parenting stress measured via the PSI 
Dysfunctional Parent-Child Interactions subscale [r (168) = .31, p <.001] and the PSI 
Difficult Child subscale [r (168) = .26, p < .001], such that elevated depression symptoms 
were associated with greater parenting stress scores. Lower subjective SES relative to 
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one’s own community was significantly associated with higher parenting stress per PSI 
Dysfunctional Parent-Child Interaction scores [r (168) = -.18 p = .03] and PSI Difficult 
Child scores [r (168) = -.21, p = .003]. Parent ACE score was positively associated with 
depression symptoms [r (168) = .19, p = .01] and cigarette use [r (168) = .24, p = .003], 
indicating parents exposed to greater childhood adversity were more likely experience 
depression symptoms and smoked more cigarettes per day. Parent age was positively 
associated with waist circumference [r (168) = .25, p = .001] and BMI [r (168) = .18, p = 
.02], as well as educational attainment [r (168) = .33, p <.001]. Educational attainment 




     
Baseline Descriptive Statistics for All Study Variables within Full Sample and by Treatment 
Condition  Full Sample Treatment Group Control Group 
Variable M SD M SD M SD 
Parent CRP mg/L (raw) 2.29 3.20 2.14 2.83 1.69 1.91 
PSI: Dysfunctional  22.93 6.42 23.04 6.42 22.82 6.30 
PSI: Difficult Child 30.02 7.41 30.34 7.84 29.02 7.60 
Depression T-Score 55.86 9.34 56.00 9.42 55.64 9.33 
Waist  (cm) 102.37 22.56 100.14 18.0
3 
101.62 19.52 
BMI 30.40 7.38 30.56 7.64 31.25 10.28 
Cigarettes/day 4.53 6.31 3.90 5.93 5.37 7.00 
Subjective SES: 
Community 
5.01 1.87 5.93 2.04 6.05 1.66 




Table 2.1            
Zero-Order Correlations Among All Baseline Study Variables in Full Sample – Imputed Data 
Variable 1 2 3 4 5 6 7 8 9 10 11 12 
1. Log CRP ___            
2. PSI: Dysfunctional 
Interactions 
-.06 ____           
3. PSI: Difficult Child -.02 .67** ____          
4. Parent Depression score -.03 .31** .26** ___
_ 
        
5. Parent ACE score  
 
-.11 .02 .04 .19* ___        
6. Parent BMI .53** .06 .08 .06 -.04 ___       
7. Parent Waist Circumference .47** .05 .12 .06 -.06 .83** ___      
8. Cigarettes/day -.05 .06 .15 .20* .24** .11 .09 ___     
9. Parent Age .04 -.08 -.08 .05 .10 .18* .25** .06 ___    
10. Parent Education .05 -.10 .00 -.04 -.05 .13 .12 -.20* .33** ___   
11. Subjective SES: Community -.05 -.18* -.21** -.15 -.09 -.03 -.08 -.03 .05 .05 ___  
12. Subjective SES: U.S. -.05 -.08 -.14 -.14 -.03 -.02 -.09 -.05 .03 .30** .41** ___ 





Table 2.2             
Zero-Order Correlations Among All Baseline Study Variables in In Full Sample – Complete Cases     
Variable 1 2 3 4 5 6 7 8 9 10 11 12 
1. Log CRP ___            
2. PSI: Dysfunctional 
Interactions 
-.01 ____           
3. PSI: Difficult Child .02 .68** ____          
4. Parent Depression score -.00 .31** .26** ____         
5. Parent ACE score  
 
-.19 .07 .05 .24* ___        
6. Parent BMI .53** .09 .05 .09 -.02 ___       
7. Parent Waist Circumference .54** .09 .06 .05 -.09 .88** ___      
8. Cigarettes/day -.15 .02 .10 .20* .24** .05 .07 ___     
9. Parent Age -.01 -.04 -.07 .14 .11 .16 .18* .16 ___    
10. Parent Education .05 -.08 .00 -.06 -.05 .12 .10 -.21* .25* ___   
11. Subjective SES: 
Community 
-.12 -.23* -.26** -.23** -.09 -.12 -.15 -.04 .06 .07 ___  
12. Subjective SES: U.S. -.02 -.15 -.23* -.20** -.08 -.14 -.18 -.12 .04 .30** .44** ___ 


















          
 Zero-Order Correlations Among All Baseline Study Variables for Treatment Group – Imputed Data  
Variable 1 2 3 4 5 6 7 8 9 10 11 12 
1. Log CRP ___            
2. PSI: Dysfunctional  -.20 ____           
3. PSI: Difficult Child -.14 .68** ____          
4. Parent Depression score -.20 .29** .22* ____         
5. Parent ACE score  
 
-.17 -.02 -.07 .14 ___        
6. Parent BMI .49** -.05 -.05 .02 -.12 ___       
7. Parent Waist Circumference .42** -.10 -.05 .01 -.16 .77** ___      
8. Cigarettes/day -.06 -.05 .03 .07 .29** .13 .05 ___     
9. Parent Age .20 -.08 -.03 .06 .05 .29** .41** .03 ___    
10. Parent Education -.06 -.22 -.19 -.12 .02 .03 .06 -.15 .17 ___   
11. Subjective SES: 
Community 
-.03 -.11 -.24* -.25* -.13 -.04 -.12 -.03 -.04 .24 ___  
12. Subjective SES: U.S. .08 -.09 .12 -.19 -.08 -.07 -.16 -.05 .03 .32* .35** ___ 




Table 2.4             
Zero-Order Correlations Among All Baseline Study Variables for Control Group – Imputed Data     
Variable 1 2 3 4 5 6 7 8 9 10 11 12 
1. Log CRP ___            
2. PSI: Dysfunctional 
Interactions 
-.06 ____           
3. PSI: Difficult Child -.02 .67** ____          
4. Parent Depression score -.03 .31** .27** ____         
5. Parent ACE score  
 
-.11 .02 .04 .19* ___        
6. Parent BMI .53**
- 
.06 .08 .06 -.04 ___       
7. Parent Waist Circumference .47** .05 .12 .06 -.06 .83** ___      
8. Cigarettes/day -.05 .06 .15 .20* .24*
* 
.11 .09 ___     
9. Parent Age .04 -.08 -.08 .05 .10 .18* .25*
* 
.06 ___    
10. Parent Education .14 -.04 .10 .01 -.09 .22* .16 -.27* .43*
* 
___   
11. Subjective SES: 
Community 
-.05 -.19* -.21** -.15 -.09 .03 -.08 -.15 -.05 .03 ___  
12. Subjective SES: U.S. -.05 -.08 -.14 -.14 -.03 .03 -.09 -.05 .03 .29** .41** ___ 
Note. * = p < .05, ** = p < .01. 
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 I further examined zero-order correlations among pre-treatment study variables 
separately by treatment group, using imputed data. Associations among variables were observed 
in the treatment (Table 2.3) and SAU control conditions (Table 2.4) were aligned with those 
found in the full sample, with a few exceptions. There was a unique, negative association 
between BSI depression symptoms and subjective community SES, [r (101) = -.25, p = .02] in 
the treatment group, such that lower perceived community standing related to greater depression 
symptoms. Within the treatment condition, the correlation between ACE score and depression 
symptoms found in the full sample was not observed, nor were associations between educational 
attainment, age, and cigarette use.  
 Table 3.1 shows zero-order correlations among post-treatment variables (i.e., CRP, 
parenting stress, BMI, and depression scores) and baseline parent characteristics, using imputed 
data. Similar to baseline, post-treatment BSI depression scores were positively correlated with 
parenting stress indices [Dysfunctional Parent-Child Interactions: r (168) = .26, p = .02; Difficult 
Child: r (168) = .44, p <.001]. Scores from the post-treatment PSI Difficult Child subscale were 
also negatively associated with subjective SES ratings relative to the entire U.S. [r (168) = -.17, p 
= .04]. Post-treatment BSI depression scores were positively related to ACE scores [r (168) = 
.19, p = .03]. Findings varied only slightly when using complete cases (see Table 3.2). 
Specifically, the associations between parent age and post-treatment BMI and between parent 
ACE score and depression symptoms were not replicated in the observed data. I again further 
explored zero-order correlations using imputed data at post-treatment separately for the PCIT 
treatment (Table 3.3) and the SAU control group (Table 3.4). Several of the zero-order 
correlations reported for the full sample were not present when I partitioned parents by treatment 
condition. PSI Difficult Child scores were not associated with subjective SES in either the 
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treatment (see Table 3.3) or control group (see Table 3.4) when considered separately, and there 
was no association between post-treatment parent depression symptoms and ACE scores within 
the treatment group (see Table 3.3).  
Characterizing Parent CRP in Current Sample 
 Baseline parent CRP. To inform selection of covariates and to explore patterns of parent 
CRP in this socially disadvantaged sample, I first conducted descriptive analyses to visualize the 
range of CRP scores at baseline as they relate to parent sociodemographic characteristics. Zero-
order correlations between baseline CRP and all other study variables are shown using imputed 
data in Table 2.1 and using complete cases in Table 2.2. Results did not differ across these 
analyses and specific statistical results described below are from the imputed data, unless 
otherwise noted. For ease of interpretation, all figures were produced using the observed data. 
Before excluding parents with extremely high CRP levels indicative of acute rather than chronic 
inflammation, CRP values in the current sample ranged from .00 mg/L to 22.00 mg/L, with 9 
parents showing baseline CRP levels indicative of acute infection. Figures 1 shows distributions 
for parents’ raw, DBS CRP concentrations at pre- and post-treatment. After excluding extremely 
high cases, the average parent CRP level reflected low levels of chronic inflammation (M = 2.39, 
SD = 3.17). However, considerable variability was observed and CRP levels associated with 
chronic, low-grade inflammation (i.e., between 3.0 mg/L and 9.9 mg/L) were present for 30 






           
Zero-Order Correlations Among Post-Treatment Parent CRP and Study Variables for Full Sample - Imputed Data  
Variable 1 2 3 4 5 6 7 8 9 10 11 12 
1. Log Post-Tx CRP ___            
2. Post-Tx PSI: 
Dysfunctional  
-.02 ___           
3. Post-Tx PSI: Difficult 
Child 
-.03 .75** ___          
4. Post-Tx Depression 
Score 
-.06 .26** .44** ___         
5. Post-Tx BMI .30** -.05 -.04 -.00 ___        
6. Waist (cm) .46** .09 .09 .01 .42** ___       
7. Parent ACE score  
 
-.11 -.02 .04 .19* -.07 -.06 ___      
8. Cigarettes/Day -.06 .03 .14 .13 .14 .09 .24** ___     
9. Parent Age  .22* .03 .01 .13 .07 .25** .10 .06 ___    
10. Parent Education .11 -.11 -.10 -.07 .14 .14 .00 -.15 .31*
* 
___   
11. Subjective SES: 
Community  
.13 -.01 -.17 -.01 -.02 -.09 -.09 -.03 .06 .05 ___  
12. Subjective SES: U.S. -.11 -.10 -.17* .01 .00 -.09 -.03 -.05 .03 .29** .42** ___ 
  




         
Zero-Order Correlations Among Post-Treatment Parent CRP and Study Variables for Full Sample – 
Complete Cases 
Variable 1 2 3 4 5 6 7 8 9 10 11 
1. Log Post CRP ___           
2. Post PSI: Dysfunctional  .15 ___          
3. Post PSI: Difficult Child .19 .73*
* 
___         
4. Post Depression Score -.07 .36*
* 
.51** ___        
5. Post BMI .56** .00 -.01 -.07 ___       
6. Waist (cm) .56** .23 .20 .01 .31*
* 
___      
7. Parent ACE score  
 
-.15 .12 .18 .21 -.12 -.06 _
_
_ 
    





___    
9. Parent Age  .18 .19 .25 .19 .07 .18 .
1
1 
.21* ___   





.25* ___  
11. Subjective SES: 
Community  





-.03 .06 .01 ___ 

















Table 3.3           
 
Zero-Order Correlations Among Post-Treatment  Parent CRP and Study Variables for Full Sample – Complete Cases 
Variable 1 2 3 4 5 6 7 8 9 10 11 
1. Log Post CRP ___ -.10          
2. Post PSI: Dysfunctional 
Parent-Child Interactions 
-.01 ___          
3. Post PSI: Difficult Child -.08 .74** ___         
4. Post Depression Score -.08 .19 .39** ___        
5. Post BMI .50** -.06 -.11 -.05 ___       
6. Waist (cm) .45** .01 -.03 -.09 .55** ___      
7. Parent ACE score  
 
-.16 -.04 .09 .05 -.15 -.16 ___     
8. Cigarettes/Day -.05 -.08 .08 -.03 .18 .05 .30*
* 
___    
9. Parent Age  .25* -.00 -.01 .01 .15 .41*
* 
.05 .03 ___   
10. Parent Education .10 -.04 .10 -.00 .20 .14 .01 -.11 .38*
* 
___  
11. Subjective SES: 
Community  
.17 -.00 -.17 -.08 -.00 -.12 -.13 -.03 -.04 -.07 ___ 
12. Subjective SES: U.S. -.13 -.12 -.15 -.00 -.00 -.16 -.08 -.06 .04 .29*
* 
.35** 











           Table 3.4 
Zero-Order Correlations Among Post-Treatment Parent CRP and Study Variables for Control Group 
Variable 1 2 3 4 5 6 7 8 9 10 11 
1. Log Post CRP ___           
2. Post PSI: Dysfunctional Parent-
Child Interactions 
-.02 ___          
3. Post PSI: Difficult Child .06 .77** ___         
4. Post Depression Score -.02 .36** .42** ___        
5. Post BMI .15 -.03 .01 .01 ___       
6. Waist (cm) .46*
* 
.23 .28* .18 .33*
* 
___      
7. Parent ACE score  
 
.00 .01 -.06 .41** .01 .10 ___     
8. Cigarettes/Day -.08 .14 .20 .20 .09 .11 .16 ___    
9. Parent Age  .16 .08 -.14 .19 -.00 .01 .20 .09 ___   
10. Parent Education .15 -.05 -.29* -.17 .20 .15 -.02 -.22 .19 ___  
11. Subjective SES: Community  .06 -.03 -.18 -.09 -.04 -.03 .01 -.03 .23 .22 ___ 
12. Subjective SES: U.S. -.07 -.07 -.20 .02 .01 .01 .06 -.05 .03 .29* .56** 
Note. * = p < .05, ** = p < .01. 
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Baseline CRP levels based on the imputed data were not statistically significantly 
different between mothers (n = 85, M = 1.80, SD = 2.00) and fathers (M = 1.33, SD = 
1.66; see Figure 5), t (166) = -1.04, p = .30. Figure 6 shows mean CRP levels partitioned 
by parent race/ethnicity. Note that the cell sizes are small for non-White parents 
participating in the study (i.e., n = 101 White, 4 Hispanic/Latino/a, 3 Black/African 
American, 2 Pacific Islander 3 Native American, 36 Multi-ethnic or unknown). As 
depicted in Figure 7, pre-treatment CRP levels were not significantly associated with 
parent age, based on complete data [r (168) = .04, p = .59]. There was a statistically 
significant, positive association between a parent’s baseline CRP and their waist 
circumference [r (168) = .47, p <.001] and BMI [r (168) = .53, p <.001], suggesting 
obesity was associated with higher CRP concentrations. CRP levels were not correlated 
with parent cigarette use [r (168) = -.05 p = .61], annual household income [r (168) = .02, 
p = .81], or, as shown in Figure 8, subjective ratings of their SES either within their own 















There was also a lack of associations in this sample between baseline measures of 
parent CRP and psychosocial risk indicators. Figure 11 shows mean CRP levels by parent 
ACE score; baseline CRP was not related to adverse childhood experiences [r (168) = -
Figure 6. Mean baseline parent CRP levels by parent race/ethnicity.  
Figure 7. Associations between baseline parent CRP and parent age. 
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.11, p = .25] or to their BSI depression symptoms [see Figure 10; r (168) = -.03, p = .76]. 
Further, baseline CRP concentrations were not associated with baseline parenting stress 
across either the PSI Dysfunctional Parent-Child Interactions subscale [r (168) = -.02, p = 
.63] or PSI Difficult Child subscale [r (168) = -.03, p = .61]. Zero-order correlations 
between baseline CRP and all other baseline study variables within the full sample are 
summarized in Table 2.1. I further explored whether associations between baseline CRP 
and psychosocial risk variables may vary across treatment group (shown in Table 2.3) 
and control group (see Table 2.4); however, the pattern of associations between CRP and 
other study variables did not differ within each treatment group, compared to full sample 
estimates. 
Post-treatment parent CRP. At post-treatment, 3 parents displayed extremely 
high CRP indicative of frank infection (i.e., >10mg/L) and 20 parents (19.8% of sample) 
displayed CRP within a range indicating chronic, low-grade inflammation (i.e., between 
3.0 mg/L and 9.9 mg/L; see Figure 1). After excluding those with extremely high levels, 
the mean post-treatment CRP level was 2.02 mg/L (SD = 2.39). Thus, a majority of 
parents showed post-treatment CRP concentrations within a healthy range, although 
elevations were, again, observed in a subset of parents.  
Results drawn from imputed data are shown in Table 3.1 and results using 
complete case analysis are shown in Table 3.2; findings did not differ across datasets and 
correlation results reported below are from the imputed data results. Mean post-treatment 
CRP levels for mothers (M = 1.93, SD = 1.80) and fathers (M = 1.27, SD = 1.01; see 
Figure 12), were not statistically significant [t (166) = -1.64, p = .18]. Associations 
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between post-treatment CRP and parent age are displayed in Figure 13; based on the 
imputed data, post-treatment CRP levels were positively associated with parent age [r 
(168) = .22, p = .02]. Figure 14 shows mean levels of post-treatment CRP by parent 
race/ethnicity that appear somewhat variable across racial/ethnic groups. A one-way 
ANOVA using the observed data suggested post-treatment CRP did not vary significantly 
by parent ethnicity [F (6, 162) = .82, p = 56], although this analysis was underpowered 





Figure 8. Mean baseline parent CRP levels by subjective ratings of SES 










Figure 9. Mean baseline parent CRP levels by parent adverse childhood 
experience (ACE) score.   
 









Results drawn from imputed data are shown in Table 3.1 and results using 
complete case analysis are shown in Table 3.2; findings did not differ across datasets and 
correlation results reported below are from the imputed data results. Mean post-treatment 
CRP levels for mothers (M = 1.93, SD = 1.80) and fathers (M = 1.27, SD = 1.01; see 










between post-treatment CRP and parent age are displayed in Figure 13; based on the 
imputed data, post-treatment CRP levels were positively associated with parent age [r 
(168) = .22, p = .02]. Figure 14 shows mean levels of post-treatment CRP by parent 
race/ethnicity that appear somewhat variable across racial/ethnic groups. A one-way 
ANOVA using the observed data suggested post-treatment CRP did not vary significantly 
by parent ethnicity [F (6, 162) = .82, p = 56], although this analysis was underpowered 
due to small cell sizes. 
 
 









Figure 13. Mean post-treatment CRP levels by parent age. 
 





Similar to patterns observed in baseline data, post-treatment parent CRP showed a 
highly significant, positive association with post-treatment BMI [r (168) = .30, p <.001]. 
Parents’ waist circumference data were not available at post-treatment. Figure 15 maps 
associations between CRP and subjective SES ratings relative to a parent’s community 
(panel A) and to the entire United States (panel B). Post-treatment parent CRP was not 
associated with any measured SES indicators [household income: r (168) = .11, p = .54; 
subjective community SES: r (168) = -.13, p = .18; subjective U.S. SES: r (168) = -.11, p 
= .20]. Mean post-treatment CRP levels by parent ACE score are shown in Figure 16. 
This appears to show higher CRP scores among parents with exposure to no adverse 
childhood experiences. However, there is not a statistically significant zero-order 
correlation between post-treatment CRP and parent ACE score [r (168) = -.11, p =.31] 
and the number of parents reporting no exposure to ACEs was quite small (n =3). Post-
treatment CRP did not show associations with post-treatment depression symptoms [see 
Figure 17; r (168) = -.06, p = .51] or with parenting stress [see Figure 18; Dysfunctional 
Parent-Child Interactions: r (168) = -.02 p = .86; Difficult Child: r (168) = -.03, p = .83]. 
Associations between post-treatment CRP concentrations and other study variables did 
not differ when considered separately among treatment group parents (see Table 3.3) and 










Figure 15. Mean post-treatment CRP levels by parent subjective SES 










Figure 16. Mean post-treatment parent CRP level by adverse childhood 
experiences score.  
 









Figure 18. Associations between post-treatment parenting stress indices 





Main Analyses  
Based on these preliminary results, I determined to include parent waist 
circumference as a covariate in all main analyses, along with parent age, consistent with 
prior empirical work linking waist circumference and age with chronic inflammation, but 
not with the intervention condition (PCIT vs. SAU). I also included pre-treatment CRP 
levels as a covariate in order to examine PCIT treatment effects on post-treatment CRP, 
controlling for variation in CRP concentration at study-entry. 
Aim 1 
 To test the hypothesis that PCIT would reduce parent CRP, I conducted a series 
of one-way analysis of covariance (ANCOVA) tests in SPSS v. 26 to assess differences 
in post-treatment parental CRP between the control and intervention groups, controlling 
for parent age and waist circumference. I completed Levene’s test and confirmed that the 
assumption for homogeneity of regression was met, as well as assumption of multivariate 
normality. I assessed for multicollinearity and found that associations among included 
covariates were within acceptable limits (.04 to .50; see Table 2). To investigate possible 
sex differences in treatment response, I performed each ANCOVA test separately for 
male and female parents, in addition to the full sample. In order to address potential bias 
associated with multiple imputation, I have reported analyses below both using the 
imputed data as well as a more conservative, complete case analysis using observed data.  
Intention-to-treat approach. I first conducted ANCOVA tests using an 
intention-to-treat (ITT) approach, comparing post-treatment CRP among treatment-
assigned parents with control group-assigned parents, controlling for baseline CRP levels, 
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parent waist circumference, and parent age. Results with the imputed data revealed no 
statistically significant difference between treatment and control groups on parent post-
treatment CRP [F (1, 160) = .01, p =.36, η2 = .00]. Pre-treatment parent CRP was a 
statistically significant covariate [F (1, 160) = 25.29, p <.001, η2 = .14], as were parent 
waist-circumference [F (1, 160) = 16.81, p <.001, η2 = .10] and age [F (1, 160) = 5.10, p = 
.03, η2 = .03]. There were also no significant differences between treatment and control 
group post-treatment CRP when considering mothers [F (1, 138) = .28, p =.60, η2 = .00] 
and fathers [F (1, 17) = .39, p =.54, η2   = .02] separately. For mothers, pre-treatment CRP 
[F (1, 138) = 21.53, p <.001, η2 = .14] and waist circumference [F (1, 138) = 15.56, p 
<.001, η2 = .10] were statistically significant covariates, but age was not [F (1, 138) = 
4.11, p = .05, η2   = .03]. For fathers, none of the covariates were statistically significant, 
including pre-treatment CRP levels [F (1, 17) = .3.64, p =.07, η2   = .18], waist 
circumference [F (1, 17) = .01, p =.94, η2   = .00], or age [F (1, 17) = 4.02, p =.06, η2   = 
.19]. Results using complete case analysis also revealed no significant differences in post-
treatment parent CRP between the PCIT and control groups [F (1, 80) = .11, p =.74, η2   = 
.00]. In this model, pre-treatment CRP [F (1, 80) = 33.52, p <.001, η2   = .30] and waist 
circumference [F (1, 80) = 5.81, p =.02, η2   = .07] were statistically significant covariates, 
although parent age was not [F (1, 80) = .1.19, p =.74, η2   = .02]. 
I also conducted a repeated measures ANOVA assessing change in parent CRP 
from pre- to post-treatment, controlling for parent waist circumference and parent age. 
Time was modeled as a within-subjects factor and treatment group was modeled as a 
between-subjects factor. Results indicated that the time * treatment group interaction was 
not statistically significant, F (1, 83) = .50, p = .48, η2 = .01. After controlling for parent 
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age and waist circumference, change in CRP levels from pre- to post-treatment was not 
significantly different among parents in the PCIT and SAU control groups. Thus, there 
was no evidence that PCIT lowered parent CRP over time. 
Further, a post-hoc analysis of variance revealed no statistically significant 
differences in post-treatment parent CRP among those in the PCIT (M = 1.79, SD = .19) 
and SAU control group (M = 1.47, SD = .26), F (1, 102) = .96, p =.33, ηp2 = .01, after 
controlling for parent age and waist circumference. In this model, parent waist 
circumference was a statistically significant covariate, F (1, 102) = 26.28, p <.001, ηp2 = 
.21, parent age was not, F (1, 102) = 1.20, p =.28, ηp2 = .01. 
Per-protocol treatment-engager approach. I next used a per-protocol approach 
to test hypothesis 1 by assessing differences in post-treatment parental CRP among 
parents in the control group and a treatment engager group, defined by those parents 
assigned to the intervention group who completed at least one treatment session. 
Analyses here were not conducted separately for mothers and fathers given small n for 
fathers after partitioning by engagement group. Using the imputed data, the treatment-
engager model revealed no statistically significant differences in post-treatment CRP 
between treatment engagers and controls [F (1,134) = .46, p = .50, η2   = .00]. Baseline 
CRP was a statistically significant covariate in this model [F (1,134) = 16.10, p <.001, η2   
= .11] as were parent waist circumference [F (1,134) = 9.72, p = .002, η2   =.07] and age 
[F (1,134) = 4.66, p = .03, η2   = .03]. There was also not a significant effect of PCIT 
using the observed data [F (1,66) = .00, p = .99, η2   = .00]. In this model, baseline CRP 
[F (1,66) = 20.54, p <.001, η2   = .24] and waist circumference [F (1,66) = 7.43, p = .01, 
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η2   = .10] were statistically significant covariates, parent age was not [F (1,66) =1.91, p = 
.17, η2   = .03]. 
Per-protocol treatment-completer approach. Finally, I conduced a set of 
ANCOVAs using a per-protocol approach that compared post-treatment parent CRP 
among control group-assigned parents and parents who completed the full course of PCIT 
treatment, defined as completing all of the CDI phase and at least 3 sessions of the PDI 
phase of treatment. Using imputed data, the treatment-completer analysis showed no 
statistically significant differences in CRP levels between parents assigned to the control 
group and those who completed PCIT [F (1,95) = .34, p = .56, η2   = .00]. In this model, 
parent baseline CRP was a statistically significant covariate [F (1,95) = 9.90, p = .002, η2   
= .09] as was parent waist circumference [F (1,95) = 6.04, p = .02, η2   = .06]; parent age 
was not a statistically significant covariate [F (1,95) = .71, p = .40, η2   = .01]. Using 
complete cases, there was also not a statistically significant difference observed between 
PCIT completers and controls [F (1,48) = .02, p = .90, η2   = .00]. Pre-treatment CRP [F 
(1,48) = 8.15, p =.01, η2   = .15] and waist circumference [F (1,48) = 8.22, p =.01, η2   = 
.15] were statistically significant covariates, whereas age was not [F (1,48) = .26, p  
=.61, η2   = .01].  
Aim 2  
I conducted mediation analyses using Hayes’ PROCESS macro v. 3.5 (Hayes & 
Preacher, 2013) to assess indirect effects of PCIT on post-treatment parent CRP, through 
PSI parenting stress. Analyses were conducted separately for PSI subscales Difficult 
Child and Parent-Child Dysfunctional Interactions. Results provided no evidence of 
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indirect of PCIT on parent CRP through either PSI Difficult Child subscale (Figure 19) or 






Figure 19. Mediation model for indirect effects of PCIT on parent CRP 
through parenting stress – Difficult Child subscale.  
 
 
Figure 20. Mediation model for indirect effects of PCIT on parent CRP through 





Aim 3  
  To test the hypothesis that the effect of PCIT on parental CRP would vary based 
on parental characteristics, I next conducted a series of regression moderation analyses 
using Hayes’ PROCESS macro v. 3.5 (Model 1; Hayes & Preacher, 2013). Because 
PROCESS requires complete data and does not accommodate imputed datasets, complete 
case analysis was used for each moderation analysis described below. All interaction 
terms were derived from centered variables. I assessed multicollinearity of variables in 
each moderation model and found them to be within an acceptable range, (i.e., .10 to .50; 
see Table 2.1).  
First, I ran a hierarchical regression model to assess whether effects of PCIT on 
post-treatment parent CRP varied by parent sex, controlling for baseline CRP levels, 
parent age, and waist circumference. The overall model was statistically significant [R2 = 
.50, F (6, 78) = 13.30, p < .001]. In step 1, parent baseline CRP, age, and waist 
circumference were included. Baseline CRP was a statistically significant predictor of 
post-treatment CRP [b = .36, t (78) = 4.63, p <.001] as was parent waist circumference [b 
= .01, t (78) = 6.03, p <.001], but parent age was not [b = .00, t (78) = 1.27, p = .21]. In 
step 2, there was no significant main effect observed for either parent sex [b = .11, t (78) 
= 1.51, p = .13], or PCIT condition [b = .02, t (78) = .42, p = .68]. In the final step, an 
interaction term between PCIT and parent sex did not predict post-treatment CRP levels 
[b = .07, t (78) = .52, p = .60], nor explain additional variance in post-treatment parent 
CRP [R2 = .00., F (1, 78) = .52, p = .47]. Thus, parent sex did not moderate the effect of 
PCIT on CRP, (see Table 4.1). To explore whether inclusion of covariates may have 
limited statistical power to detect interaction effects in this small set of complete cases, I 
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additionally performed each moderation model without covariates. As shown in Table 
4.2, null main effects of PCIT group and parent sex and null effect of the interaction term 






Table 4.1       
No Evidence Parent Sex Moderates effect of PCIT on CRP, Covariates Included 
Variable B SE t Sig. 
95% Confidence 
Interval for B 
     Lower  Upper  
(Constant) -.49 .15 -3.34** .00 -.78 -.20 
Treat Group .02 .04 .42 .68 -.07 .10 
Sex .11 .07 1.51 .13 -.03 .25 
PCIT X Sex Interaction .07 .13 .52 .60 -.20 .34 
Baseline Log CRP .37 .08 4.78** .00 .22 .53 
Waist Circumference .01 .00 6.03** .00 .00 .01 
Age .00 .00 1.27 .21 -.00 .01 
Table 4.2       
No Evidence Parent Sex Moderates effect of PCIT on CRP, Covariates Excluded 
Variable B SE t Sig. 
95% Confidence Interval for 
B 
     Lower  Upper  
(Constant) .35 .02 14.60** .00 .30 .40 
Treat Group .01 .05 .10 .92 -.09 .10 
Sex .12 .08 1.52 .13 -.04 .29 
Treat X Sex 
Interaction 
.17 .16 1.06 .29 -.15 .48 
Note. * = p < .05, ** = p < .01. 
Note. * = p < .05, ** = p < .01. 
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I next conducted a hierarchical regression model to assess whether effects of 
PCIT on post-treatment parent CRP varied by parent age, controlling for pre-treatment 
CRP and waist circumference. The overall model was statistically significant, [R2  = .50, 
F(5,79) = 13.33, p < .001]. In step 1, baseline parent CRP levels [b = .36, t (79) = 4., p 
<.001] and parent waist circumference [b = .01, t (79) = 6.35, p <.001] were revealed to 
be statistically significant predictors. In step 2, there was no significant main effect for 
either parent age [b = .00, t (78) = 1.20, p = .23] or PCIT condition [b = .02, t (78) = .54, 
p = .59]. In the final step, the parent age X PCIT interaction term was not a significant 
predictor of post-treatment CRP [b = -.01, t (78) = -1.49, p = .23], and did not explain 
additional variance in CRP levels [R2= .00., F (1, 78) = .64, p = .42], revealing that 
parent age did not moderate the effect of PCIT on parent CRP (see Table 5.1). Null 
results across treatment group main effect, age main effect, and their interaction term 







      
No Evidence Parent Age Moderates Effect of PCIT on CRP, Covariates Included 
Variable B SE t Sig. 
95% Confidence 
Interval for B 
     Lower  Upper  
(Constant) -.57 .26 -3.41** .00 -.90 -.24 
Treat Group .02 .04 .54 .59 -.06 .11 
Age .00 .00 1.20 .23 -.00 .02 
PCIT X Age Interaction -.01 .01 -1.49 .23 -.00 .01 
Log Baseline CRP .36 .08 4.63** .00 .21 .52 
Waist Circumference .01 .00 6.35** .00 .01 .01 






Finally, I performed a moderation analysis to examine whether intervention 
effects on parent post-treatment CRP varied by levels of parent ACE score, controlling 
for pre-treatment CRP, parent waist circumference, and age. The overall model was 
statistically significant [R2 = .49, F (6,78) = 11.50, p < .001]. In step 1, pre-treatment CRP 
[b = .38, t (78) = 4.72, p <.001] and parent waist circumference [b = .01, t (78) = 5.75, p 
<.001] were significant predictors of CRP, although parent age [b = .01, t (78) = 1.38, p 
=.17] was not. In step 2, no significant main effect was found for either PCIT condition 
[b = .02, t (78) = .42, p =.68] or parent ACE scores [b = -.01, t (78) = -1.06, p = .29]. The 
interaction term between PCIT and parent ACE scores was not a significant predictor of 
post-treatment CRP [b = -.00, t (78) = -.03, p = .98] and did not explain added variance in 
post-treatment parent CRP levels [R2= .00., F (1, 78) = .25, p = .62]. Therefore, parent 
ACE scores did not moderate the effect of PCIT on parent CRP (see Table 6.1). Null 
results for main effect of treatment group and parent ACE score as well as their 
interaction were also obtained when this analysis was performed without covariates  
Table 5.2       
No Evidence Parent Age Moderates Effect of PCIT on CRP, Covariates Excluded 
Variable B SE t Sig. 
95% Confidence Interval 
for B 
     Lower  Upper  
(Constant) .35 .02 14.74** .00 .30 .40 
Treat Group .03 .05 .61 .55 -.07 .13 
Age .01 .00 2.04* .04 .00 .02 
Treat X Age 
Interaction 
-.00 .01 -.29 .78 -.02 .02 

















Table 6.1  
No Evidence Parent ACE Score Moderates Effects of PCIT on CRP, 
Covariates Included 
 
Variable B SE t Sig. 
95% Confidence 
Interval for B 
     Lower  Upper  
(Constant) -.66 .20 -3.27** .00 -1.06 -.26 
Treat Group .02 .04 .42 .68 -.07 .10 
ACE Score -.01 .01 -1.06 .29 -.02 .01 
Treat X ACEs 
Interaction 
-.00 .02 -.03 .98 -.03 .04 
Log Baseline CRP .38 .08 4.72** .00 .22 .54 
Waist Circumference .01 .00 5.75** .00 .00 .01 
Age .01 .00 1.38 .17 -.00 .01 
Table 6.2 
No Evidence Parent ACE Score Moderates Effects of PCIT on CRP, Covariates 
Excluded 
Variable B SE t Sig. 
95% Confidence Interval 
for B 
     Lower  Upper  
(Constant) .35 .02 14.94** .00 .31 .40 
Treat Group .01 .05 .23 .82 -.09 .10 
ACE Score -.02 .01 -1.43 .16 -.03 .01 
Treat X ACE 
Interaction 
-.02 .02 -.99 .32 -.06 .02 
Note. * = p < .05, ** = p < .01. 






The current study aimed to investigate effects of PCIT on a biomarker of chronic 
inflammation (i.e., CRP) among child welfare-involved parents, to test parenting stress as 
a possible mediator of treatment effects, and to explore parent characteristics (i.e., age, 
sex, exposure to adverse childhood experiences) that may moderate effects of PCIT on 
CRP. Given that brief, behavioral therapies (i.e., mind-body therapies and cognitive 
behavior therapy; Bowen & Irwin, 2016; Lopresti, 2017) have been shown to confer 
inflammatory benefits in adults and one study documented lower inflammation among 
youth following a parent training program (Miller et al. 2014), I hypothesized that PCIT 
would reduce parent chronic inflammation. Based on broad knowledge that the quality of 
key relationships influences physical health (Kiecolt-Glaser et al., 2010; Umberson et al., 
2010) and limited evidence that relational stress may predict levels of inflammatory. 
markers over time, at least in adolescents (Chiang et al., 2012; Fuligni et al., 2009), I 
posited that PCIT would reduce parent inflammation through lowering parenting stress, a 
well-documented outcome of PCIT (Thomas et al., 2017). I also sought to explore parent 
characteristics and risk factors that may moderate effects of PCIT on CRP, and expected 
that treatment effects may be amplified among older parents, female caregivers, and 
parents with greater exposure to adverse childhood experiences. Overall, study 
hypotheses were not supported. Results provided no evidence that post-treatment CRP 
was lower among parents randomized to PCIT, relative to the family services-as-usual 
control, and no evidence that parenting stress levels were related to parents’ CRP 
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concentrations at either study entry of post-treatment. Moreover, there was no evidence 
of treatment effects on CRP when parent age, parent sex, or parent ACE scores were 
considered as moderators.  
Patterns of CRP in Current Sample 
 A range of parent CRP levels were observed in the current sample, including 
levels indicative of chronic, low-grade inflammation. At baseline, although a majority of 
parents displayed low, healthy levels of CRP, indicating an absence of peripheral 
inflammation, CRP concentrations suggesting chronic, low-grade inflammation (i.e., > 
3.0 mg/L but <10.0 mg/L) were displayed by approximately one third of parents. Further, 
parents reported high rates of sociodemographic characteristics and health factors 
typically associated with chronic, low-grade inflammation. Over half of study parents 
were obese and reported daily cigarette use. Parents were also predominantly low-income 
(i.e., nearly half reported receiving financial aid from Department of Human Services) 
and reported high rates of adversity in their own childhoods (nearly three-quarters 
reported four or more ACEs). A large, significant, positive association was observed 
between parents’ CRP levels and their BMI and waist circumference, showing that, 
consistent with prior research (Brooks et al., 2010), obesity was a strong predictor of 
chronic inflammation in this sample. However, parent CRP was not significantly related 
to any other parent characteristics (i.e., age, sex, race/ethnicity) or common psychosocial 
risk factors for inflammation (i.e., income, subjective SES, ACE score, cigarette use, 
depression symptoms).  
This lack of associations is surprising, given the literature base documenting that 
chronic inflammation is related to psychosocial risk factors such as childhood adversity 
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(Nusslock & Miller, 2016; Lob, Lacey, & Steptoe, 2019) and current, low SES 
(Gruenewald et al., 2009). One possible explanation for the lack of associations between 
parent CRP and psychosocial risk factors in our sample is the high rate of parent 
medication use prior to collecting dried blood spots (DBS). Although data were excluded 
from the main analyses for parents who reported use of major anti-inflammatory 
medications (e.g., NSAIDs, acetaminophen, antihistamines), over two-thirds of parents 
reported use of any medication prior to the post-treatment assessment, and many parents 
reported multi-medication use. Thus, while steps were taken to attempt to control for 
parent medication use, substantial medication use remained among parents who were 
retained in the study, which may have obscured true patterns of chronic inflammation in 
this sample. This notion is in line with previous studies that have reported null effects of 
behavioral interventions and failed to find associations between CRP and psychosocial 
variables when participants reported high rates of medication use (Antoni et al. 2009; 
Claesson et al., 2006; Hermanns et al., 2015).  
Behavioral Interventions to Reduce Inflammation 
No previous study has examined potential impacts of PCIT on parental 
inflammation. While the current investigation was a novel effort, findings from other 
behavioral interventions shown to impact inflammatory processes in adults can offer 
insight regarding the conditions under which CRP changes might be expected. Mind-
body therapies (MBTs), including yoga, Tai Chi, Qigong, and meditation-based therapies 
such as Mindfulness-Based Stress Reduction, have been shown through randomized 
controlled trials to reduce circulating CRP (Chen, 2010; Lavretsky et al., 2011; Malarkey 
et al., 2013) as well as cellular markers of inflammation (Irwin et al., 2014, 2015; 
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Kiecolt-Glaser et al. 2014) and pro-inflammatory gene expression (Black et al., 2013; 
Bower et al. 2014). Inflammation lowering effects of MBTs have been recorded in 
healthy adults (Chen, 2006), adults receiving complementary treatment for medical 
conditions (Chen, 2010; Oh, et al., 2012), and older adults (Irwin & Olmstead, 2012). 
However, a number of other MBT studies have returned null results on inflammation (see 
Bower & Irwin, 2014 for a review). Cognitive behavioral therapy (CBT) has also been 
shown to reduce circulating inflammatory markers in adults receiving treatment for 
depression or medical condition-related stress (e.g., Huebner et al., 2016; Moreira et al., 
2015), although findings in this literature are mixed as well (see Lopresti, 2017 for a 
review). What are the mechanisms by which MBTs and CBT impact inflammation, and 
how might these differ from treatment mechanisms of PCIT? 
Mechanisms of Behavioral Interventions that Lower Inflammation 
Broadly speaking, MBTs are thought to operate through reducing stress reactivity 
(Bower & Irwin, 2014). Although MBTs encompass a diverse set of practices, active 
ingredients shared across interventions have been identified as breathing practice, 
focused attention, and physical movement (Bower & Irwin, 2014). There is some 
evidence that physical movement may be a critical component for reducing CRP in 
particular; one meta-analysis of MBT effects reported CRP reductions only in trials 
employing yoga, Tai Chi, or Qigong, but not meditation interventions (Morgan et al., 
2014). Further, across modalities, MBTs share an emphasis on daily practice of stress 
reduction techniques (Bower & Irwin, 2014). Less is known about potential mechanisms 
by which CBT may reduce inflammation. CBT generally focuses on improving coping 
with stress and negative emotion, and it has been proposed (Lopresti, 2017) that CBT 
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may lower inflammation either through the use of coping strategies which reduce stress 
(Kang et al., 2011), or through lifestyle improvements that result from positive coping 
practice. For example, engagement in daily pleasurable activities may serve to increase 
physical activity levels (Sin, Graham-Engeland, & Almeida, 2015) and relaxation 
practices may lead to improved sleep (Irwin, Olmstead, & Carroll, 2016). Indeed, some 
of the largest effect sizes for intervention-driven CRP reductions in Lopresti’s 2017 
review were observed in studies of CBT for Insomnia (CBT-I; Chen et al., 2011; Irwin et 
al., 2014, 2015). Thus, although the primary therapeutic goal of MBTs and CBT is to 
reduce stress (reduce stress reactivity in MBTs, improve coping with stress in CBT), their 
effects on inflammation may, in fact, be driven by improvements in health behavior such 
as sleep and physical activity that are either directly targeted (as in Yoga, Qigong, Tai 
Chi, and CBT-for Insomnia) or indirectly influenced by teaching positive coping 
strategies (as in CBT).  
In contrast to MBTs and CBT, which work to reduce stress through a broad range 
of lifestyle improvements, PCIT more narrowly targets the quality of the parent-child 
relationship by increasing positive parenting behaviors and reducing harsh parenting 
behaviors. If improvements in sleep and physical activity are, in fact, critical components 
of MBTs and CBT for inflammation, then it could be that a strictly psychosocial 
intervention, such as PCIT, is unlikely to affect immune processes. More research on 
these interventions is needed with study designs that allow for possible mechanisms to be 
compared in order to disentangle the effects of stress reduction versus health behavior 
improvement on inflammation. However, there is evidence that MBTs also have the 
capacity to target neural mechanisms involved in threat reactivity processing (Creswell & 
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Lindsay, 2014), suggesting that intervention-driven improvements in stress reactivity 
may influence inflammatory processes. For example, MBTs have been shown to decrease 
sympathetic nervous system activity and increase parasympathetic nervous system 
activity, both at rest and in response to a stressor (Audette et al., 2006; Creswell & 
Lindsay, 2014: Motivala et al., 2006). There is also some evidence that meditation 
practice is associated with decreased activity in the amygdala (Golden & Gross, 20101; 
Taren et al., 2015), a brain region involved in responding to threat. Such intervention-
related improvements in neural threat reactivity and sympathovagal balance may in turn 
lower inflammation through reduced adrenergic signaling (Nusslock & Miller, 2016), 
leading to the post-MBT reductions in circulating CRP seen in some studies (Bower & 
Irwin, 2016). Thus, while changes in health behavior likely account for some of the 
effects on inflammation seen in CBT and MBTs, evidence of changes in physiological 
stress responses systems that operate upstream from the immune system seem to suggest 
that intervention-driven improvements in stress reactivity also play a role in lowering 
inflammation.  
Furthermore, findings by Miller and colleagues (Miller, Brody, Yu, & Chen, 
2014) have demonstrated that a strictly psychosocial parenting intervention can lower 
inflammation, albeit among adolescents, rather than parents. In their longitudinal trial of 
Strong African American Families, a 7-week positive parenting program delivered to 
low-income families in the rural South, they found that youth of parents who received the 
intervention showed lower levels of six pro-inflammatory cytokines at an 8-year follow-
up, relative to controls. These findings are also consistent with some evidence from 
observational, longitudinal studies which show that adolescents’ reports of stress or 
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conflict in close family and friend relationships correspond to levels of inflammatory 
markers over time (Chiang et al, 2012; Fuligni et al., 2009). In light of this evidence, why 
were inflammation reductions not observed from PCIT, an intervention known to show 
robust effects in strengthening the parent-child relationship (Thomas et al., 2017)? The 
treatment goals of PCIT are similar to SAAF and include improving parent-child 
relationships and building child socioemotional competency (Brody et al., 2004; Eyberg 
et al., 1995). PCIT is a more intensive parenting intervention, delivered individually with 
live coaching versus the group format used in SAAF. PCIT intervention dosage is higher 
also higher compared to SAAF; in the current study, families received an average of 12 
treatment sessions compared to the 7 sessions reported by Miller et al. (2014).  
One explanation is that improvements in the parent-child relationship may be 
more salient for the immune systems of children, compared to caregivers. Developmental 
science has established the critical importance of the quality of early caregiving for the 
developing neuroendocrine stress response systems of children (Kuhlman, Chiang, 
Horne, & Bower, 2017; Nusslock & Miller, 2016). Although it is not yet clear at which 
stage in development the effects of the early environment on immune response may 
manifest, there is evidence that exposure to maltreatment (Coehlo, Viola, Walss-Bass, 
Brietzke, & Grassi-Oliveira, 2014) or harsh parenting (Brody, Yu, Beach, Kogan, 
Windle, & Philibert, 2014) in early and middle childhood impacts immune responding 
and may lead to chronic inflammation by adolescence (Brody et al., 2014). Thus, there is 
a strong empirical and theoretical basis for Miller and colleagues’ 2014 finding that a 
positive parenting program delivered in middle childhood protected against immune 
dysregulation for vulnerable youth over the following 8 years. In contrast, research has 
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not delineated whether parents’ stress response systems are more or less impacted by the 
quality of interactions with their child, compared to the quality of other key relationships, 
or to more global levels of psychosocial stress. It may be that changes in the quality of 
the parent-child relationship have less impact on the stress response systems (and, in turn, 
inflammatory processes) of adult caregivers, relative to the profound developmental 
significance the quality of this relationship has for a child. This notion appears to be 
supported by the fact that each of the findings reviewed here showing significant 
associations between the quality of the parent-child relationship and inflammation, either 
as observed over time (Chiang et al., 2012; Fuligni et al., 2009; Marin et al., 2009) or 
driven by intervention (Miller et al., 2014), involved adolescents or young adult 
offspring. However, the paucity of research examining the effect of the parent-child 
relationship on parent stress responding makes it difficult to draw conclusions here.  
Another notable difference between the current study and Miller and colleagues’ 
2014 study is the length to follow-up for testing intervention-related effects on 
inflammation. Miller et al. (2014) found treatment effects on youths’ inflammation 8 
years following treatment, whereas we found no effects on CRP immediately following 
treatment completion. Thus, an alternative explanation is that, within the current study 
design, CRP was simply assessed too early to allow for potential changes to be detected. 
PCIT is known to have powerful effects on improving parenting behavior (Batzer et al., 
2018; Cooley et al., 2014) and reducing child problem behavior (Thomas et al, 2017). 
However, it is possible that behavioral gains evident at post-treatment do not translate 
into corresponding neurobiological improvements until later. While it is unknown how 
long after competing PCIT changes in CRP would be expected to emerge, findings from 
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the mind-body therapy (MBT) literature offer clues about the time course of intervention-
driven changes in inflammation. As reviewed by Bower and Irwin (2014), effects 
immediately following an MBT intervention are most often reported on inflammatory 
gene-expression pathways (e.g., Black, Irwin, Olmstead, Crabb Breen, & Motivala, 2014; 
Creswell et al., 2012), whereas effects on circulating pro-inflammatory markers appear to 
emerge over a longer period. For example, in their RCT assessing effects of a 12-week 
yoga intervention on inflammation among 200 breast cancer survivors, Kiecolt-Glaser 
and colleagues (2014) found no effect on Il-6, TNF, and IL-1 immediately following 
treatment, but did observe reductions at a 3-month follow-up (Kiecolt-Glaser et al., 
2014). Moreover, because CRP production is regulated in part by IL-6, CRP changes 
occur slightly further downstream in the inflammatory process and may not be detectable 
as early as changes in IL-6 and other inflammatory cytokines. Illustrating this, among the 
small subset of MBT trials reviewed by Bower & Irwin (2014) that focused on Tai Chi 
among older adults, IL-6 reductions were observed in one study as early as 16 weeks 
post-intervention (Irwin & Olmstead, 2012), whereas Tai Chi-related reductions in CRP 
were observed in a similar study after 24 weeks (Lavretsky et al., 2011). Taken together, 
evidence suggests that the brief longitudinal design of the current study may have limited 
our ability to accurately assess intervention-related CRP changes. It is possible that CRP 
changes could have been observed in the current sample if measured via proinflammatory 
gene expression, or that changes in circulating CRP may have emerged if assessed at a 6- 






 Hypotheses in the current study were not supported; I found no evidence that 
PCIT impacted parent CRP levels at post-treatment and no evidence that parents’ CRP 
levels were associated with their parenting stress. Based on literature review of other 
behavioral interventions shown to impact inflammation (Bower & Irwin 2014: Lopresti, 
2017), it is possible that PCIT does not affect inflammation because it does not involve 
improvements in health behaviors such as sleep and physical activity or because it 
narrowly focuses on improving the parent-child relationship, rather than reducing stress 
more broadly. Reducing stress reactivity, in particular, appears to be a critical mechanism 
driving the neuroendocrine changes in mind-body therapies that lead to lower 
inflammation (Bower & Irwin, 2014). Alternatively, it may be that the brief longitudinal 
design here did not allow for CRP changes to be captured over the period in which they 
may emerge. However, much remains to be learned about potential benefits of PCIT for 
parents. Future studies should assess whether PCIT reduces stress reactivity and examine 
potential effects of PCIT on other physiological systems, such as the HPA-axis or 
autonomic nervous system, to learn whether positive behavioral outcomes of PCIT may 
confer benefits on more upstream processes in the body’s response to stress. Results of 
such studies could help determine whether continued investigation of PCIT and chronic 
inflammation are warranted.  
 Although parent CRP levels were related only to parent BMI and waist 
circumference in the current study, parents did show high rates of several other risk 
factors for chronic inflammation, such as daily cigarette use, elevated parenting stress and 
depression symptoms. Moreover, these psychosocial risk factors were higher among 
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parents who reported greater exposure to adverse childhood experiences or lower 
subjective SES. This highlights how multiple risk factors for poor health outcomes can 
accumulate among socially disadvantaged individuals, such as parents involved with 
child welfare. PCIT is known to be an effective intervention for reducing child 
maltreatment (Chaffin et al., 2011), one critical public health problem experienced by 
child welfare-involved families. Continued research is needed to identify preventive 
interventions that can target the range of health problems these families may face, in 
order to reduce the burden of stress-related disease in these populations. 
Study Strengths 
 The current study used data from a randomized controlled trial (RCT) design, 
which bolstered internal validity in examining the impact of PCIT on parent low-grade 
inflammation. Collection of parent measures at pre- and post-treatment allowed the 
ability to assess CRP changes across a brief time period, while controlling for some 
possible confounds. The study is also strengthened by the high-risk nature of the sample 
of child-welfare involved parents. With Miller and colleagues’ work as an important 
exception (Miller et al., 2014) this population is underrepresented in research on 
behavioral treatments and inflammation, despite the fact that they may be 
disproportionately burdened by stress-related illness. Finally, the use of both ITT and per-
protocol analytic approaches maximizes the external and internal validity of conclusions 
here, by allowing for possible treatment effects to be assessed both under the most 
stringent conditions as well as under conditions most generalizable to community 




Study Limitations  
 A number of limitations in the current study should be noted. First, I relied on a 
single biomarker of chronic inflammation, CRP. Collecting a full panel of pro-
inflammatory cytokines (e.g., IL 1β, -6, -8, and -10, tumor necrosis factor α, IFN- γ) 
would have provided a more complete picture of chronic inflammation in the sample and 
strengthened internal validity. The brief longitudinal design also constrained our ability to 
detect possible changes in CRP, as we were not able to assess for changes that could have 
emerged at 3- or 6-months after parents completed PCIT, as has been documented in 
some MBT trials (e.g., Lavretsky et al, 2011). In future studies, researchers should 
consider whether there are ethical ways to limit participant medication use prior to 
collection of inflammatory markers.  
Further, there are several potential confounds in the current study. As described 
above, high rates of parent medication use may have obscured true patterns of 
inflammation in study parents and thus interfered with my ability to detect treatment 
effects or associations between psychosocial risk variables and parent CRP. There are 
also a number of health-related variables which were not assessed here but may have 
contributed to parents’ CRP levels, such as underlying parent health conditions, sleep 
quality, diet, frequency of physical exercise, and use of alcohol or caffeine. Although a 
number of measures of psychosocial risk were included (e.g., objective income and 
subjective SES, parent occupational and housing status) at pre- and post-treatment, we 
did not include a measure of other stressful life events parents may have experienced in 
the course of the study, such as death or incarceration of a loved one or new material 
hardships (e.g., loss of transportation). Researchers should incorporate measures of 
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stressful life events in future studies examining chronic inflammation, especially when 
using samples of low-income families, given they are known to experience stressful life 
disruptions more frequently (Brown et al., 2016).  
External validity may also be limited by several sample characteristics. First, 
participating parents were primarily White. Higher levels of chronic inflammation have 
been documented among non-white ethnic groups, most consistently among 
Black/African American and Hispanic/Latino/a individuals (O’Connor et al., 2009), and 
so the relatively homogenous makeup of our sample may have limited our ability to 
detect effects of PCIT on CRP, especially given evidence that behavioral interventions 
may have greater impact on reducing inflammation among participants with higher 
baseline levels of inflammation (Morgan et al., 2014). Sex is another important 
demographic factor influencing inflammation (Khera et al., 2005) and, because fathers 
made up a small portion of the sample and, it was difficult to assess how results may have 
differed by parent sex. Finally, although this study’s focus on an understudied sample of 
child welfare-involved parents is an important contribution to the literature, relatively 
high levels of psychosocial risk observed across the sample (e.g., only 3 parents reported 
no exposure to ACEs) may have limited statistical ability to uncover associations 
between psychosocial risk variables and parent CRP. The above sample characteristics 
also impact generalizability of the current results, which may not apply to non-White 






 To understand whether PCIT has the ability to confer anti-inflammatory benefits, 
more research is needed using longitudinal designs with follow-up assessments at least 3 
months after treatment completion that can measure inflammatory markers when 
intervention-related changes may emerge. To capture a more complete picture of low-
grade inflammation, researchers should also collect a full panel of circulating anti-
inflammatory cytokines in addition to CRP, and consider assessing cellular inflammatory 
markers or inflammatory gene expression pathways, as there is evidence treatment effects 
may be more readily observable in these measures of inflammation. Further, researchers 
should assess health behaviors such as physical activity and quality of sleep at pre- and 
post-treatment in order to disentangle treatment-related changes in inflammation driven 
by stress reduction versus lifestyle improvements. 
 Behavioral interventions that do lower inflammation and confer benefits across 
neuroendocrine stress response systems appear to work at least in part by reducing stress 
reactivity (Bower & Irwin, 2014). It is unknown whether the significant parent behavior 
changes observed in PCIT may be accompanied by broader improvements in stress 
reactivity, and not only improvements in parenting stress. The larger parent grant from 
which the current study is drawn aims to discover whether PCIT may improve 
biobehavioral indices of parent self-regulation, including via autonomic responding, and 
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